Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 12.427.7513.0020.39

What is the latest Core EBITDA Margin ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Margin ratio of PIRAMAL PHARMA is 12.42 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202412.42
Mar20237.75
Mar202213.00
Mar202120.39

How is Core EBITDA Margin of PIRAMAL PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 12.42
60.26
Mar2023 7.75
-40.38
Mar2022 13
-36.24
Mar2021 20.39 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Margin ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹31,777.0 Cr -0% -9.8% 53.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0%

-9.8%

53.3%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses